164 related articles for article (PubMed ID: 11166740)
1. The inducible nitric oxide synthase inhibitor ONO-1714 blunts dextran sulfate sodium colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T
Eur J Pharmacol; 2001 Jan; 412(1):91-9. PubMed ID: 11166740
[TBL] [Abstract][Full Text] [Related]
2. A novel potent inhibitor of inducible nitric oxide inhibitor, ONO-1714, reduces intestinal ischemia-reperfusion injury in rats.
Naito Y; Takagi T; Ichikawa H; Tomatsuri N; Kuroda M; Isozaki Y; Katada K; Uchiyama K; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Nitric Oxide; 2004 May; 10(3):170-7. PubMed ID: 15158697
[TBL] [Abstract][Full Text] [Related]
3. alpha-Phenyl-N-tert-butylnitrone provides protection from dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Ishikawa T; Handa O; Matsumoto N; Yagi N; Matsuyama K; Yoshida N; Yoshikawa T; Kotake Y
Antioxid Redox Signal; 2002 Feb; 4(1):195-206. PubMed ID: 11970853
[TBL] [Abstract][Full Text] [Related]
4. A potent inhibitor of inducible nitric oxide synthase, ONO-1714, a cyclic amidine derivative.
Naka M; Nanbu T; Kobayashi K; Kamanaka Y; Komeno M; Yanase R; Fukutomi T; Fujimura S; Seo HG; Fujiwara N; Ohuchida S; Suzuki K; Kondo K; Taniguchi N
Biochem Biophys Res Commun; 2000 Apr; 270(2):663-7. PubMed ID: 10753680
[TBL] [Abstract][Full Text] [Related]
5. Pioglitazone, a PPAR-gamma ligand, provides protection from dextran sulfate sodium-induced colitis in mice in association with inhibition of the NF-kappaB-cytokine cascade.
Takagi T; Naito Y; Tomatsuri N; Handa O; Ichikawa H; Yoshida N; Yoshikawa T
Redox Rep; 2002; 7(5):283-9. PubMed ID: 12688511
[TBL] [Abstract][Full Text] [Related]
6. A specific inducible nitric oxide synthase inhibitor, ONO-1714 attenuates inflammation-related large bowel carcinogenesis in male Apc(Min/+) mice.
Kohno H; Takahashi M; Yasui Y; Suzuki R; Miyamoto S; Kamanaka Y; Naka M; Maruyama T; Wakabayashi K; Tanaka T
Int J Cancer; 2007 Aug; 121(3):506-13. PubMed ID: 17417780
[TBL] [Abstract][Full Text] [Related]
7. Effects of a selective inhibitor of inducible nitric oxide synthase, ONO-1714, on experimental hemodialysis-related hypotension in renal dysfunctional dogs.
Komeno M; Akimoto A; Fujita T; Katsube N
J Pharmacol Sci; 2004 Nov; 96(3):343-6. PubMed ID: 15539758
[TBL] [Abstract][Full Text] [Related]
8. ONO-1714, a new inducible nitric oxide synthase inhibitor, attenuates diaphragmatic dysfunction associated with cerulein-induced pancreatitis in rats.
Mikawa K; Kodama SI; Nishina K; Obara H
Crit Care Med; 2001 Jun; 29(6):1215-21. PubMed ID: 11395607
[TBL] [Abstract][Full Text] [Related]
9. An inhaled inducible nitric oxide synthase inhibitor reduces damage of Candida-induced acute lung injury.
Ohsugi S; Iwasaki Y; Takemura Y; Nagata K; Harada H; Yokomura I; Hosogi S; Yuba T; Niisato N; Miyazaki H; Matsubara H; Fushiki S; Marunaka Y
Biomed Res; 2007 Apr; 28(2):91-9. PubMed ID: 17510494
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological role of nitric oxide in rat experimental colitis.
Southey A; Tanaka S; Murakami T; Miyoshi H; Ishizuka T; Sugiura M; Kawashima K; Sugita T
Int J Immunopharmacol; 1997; 19(11-12):669-76. PubMed ID: 9669207
[TBL] [Abstract][Full Text] [Related]
12. A novel inhibitor of inducible nitric oxide synthase (ONO-1714) prevents critical warm ischemia-reperfusion injury in the pig liver.
Meguro M; Katsuramaki T; Nagayama M; Kimura H; Isobe M; Kimura Y; Matsuno T; Nui A; Hirata K
Transplantation; 2002 May; 73(9):1439-46. PubMed ID: 12023622
[TBL] [Abstract][Full Text] [Related]
13. The detrimental effect of nitric oxide on tissue is associated with inflammatory events in the vascular endothelium and neutrophils in mice with dextran sodium sulfate-induced colitis.
Yasukawa K; Tokuda H; Tun X; Utsumi H; Yamada K
Free Radic Res; 2012 Dec; 46(12):1427-36. PubMed ID: 22998024
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture.
Okamoto I; Abe M; Shibata K; Shimizu N; Sakata N; Katsuragi T; Tanaka K
Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):716-22. PubMed ID: 10934111
[TBL] [Abstract][Full Text] [Related]
15. Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
Huang TY; Chu HC; Lin YL; Lin CK; Hsieh TY; Chang WK; Chao YC; Liao CL
Toxicol Appl Pharmacol; 2009 May; 237(1):69-82. PubMed ID: 19285099
[TBL] [Abstract][Full Text] [Related]
16. Enhanced intestinal inflammation induced by dextran sulfate sodium in tumor necrosis factor-alpha deficient mice.
Naito Y; Takagi T; Handa O; Ishikawa T; Nakagawa S; Yamaguchi T; Yoshida N; Minami M; Kita M; Imanishi J; Yoshikawa T
J Gastroenterol Hepatol; 2003 May; 18(5):560-9. PubMed ID: 12702049
[TBL] [Abstract][Full Text] [Related]
17. Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-alpha.
Funakoshi H; Kubota T; Machida Y; Kawamura N; Feldman AM; Tsutsui H; Shimokawa H; Takeshita A
Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2159-66. PubMed ID: 12003824
[TBL] [Abstract][Full Text] [Related]
18. An orally active matrix metalloproteinase inhibitor, ONO-4817, reduces dextran sulfate sodium-induced colitis in mice.
Naito Y; Takagi T; Kuroda M; Katada K; Ichikawa H; Kokura S; Yoshida N; Okanoue T; Yoshikawa T
Inflamm Res; 2004 Sep; 53(9):462-8. PubMed ID: 15550999
[TBL] [Abstract][Full Text] [Related]
19. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
Kankuri E; Vaali K; Knowles RG; Lähde M; Korpela R; Vapaatalo H; Moilanen E
J Pharmacol Exp Ther; 2001 Sep; 298(3):1128-32. PubMed ID: 11504810
[TBL] [Abstract][Full Text] [Related]
20. Dextran sodium sulfate-induced colitis reveals nicotinic modulation of ion transport via iNOS-derived NO.
Green CL; Ho W; Sharkey KA; McKay DM
Am J Physiol Gastrointest Liver Physiol; 2004 Sep; 287(3):G706-14. PubMed ID: 15087277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
